3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Uveal Melanoma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Lung Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Adenoma, Islet Cell
1
Interventions
pembrolizumab
4
aldesleukin
3
Cisplatin
3
lenvatinib
2
Surveys and Questionnaires
2
Specimen Handling
2
Paclitaxel
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Adoptive Transfer
2
zimberelimab
1
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
belzutifan
1
atezolizumab
1
Therapeutic Touch
1
Taxes
1
Standard of Care
1
Sonazoid
1
Respiratory Function Tests
1
Radiotherapy
1
Radiation
1
Prochlorperazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
aflibercept
×
1 year
×
Clear all
No trials found.